| Identification | Back Directory | [Name]
L-Leucine, L-arginyl-L-alanyl-L-lysyl-L-phenylalanyl-L-lysyl-L-glutaminyl-L-leucyl- | [CAS]
200124-17-0 | [Synonyms]
EBV BZLF1 (190-197)
L-Leucine, L-arginyl-L-alanyl-L-lysyl-L-phenylalanyl-L-lysyl-L-glutaminyl-L-leucyl- | [Molecular Formula]
C47H82N14O10 | [MOL File]
200124-17-0.mol | [Molecular Weight]
1003.24 |
| Hazard Information | Back Directory | [Uses]
EBV BZLF1 (190-197) is an immunodominant CEF-controlling peptide derived from Epstein-Barr virus (EBV). EBV BZLF1 (190-197) is a suitable epitope for CD8+ T cells to stimulate the release of IFNg. CTL responses to EBV BZLF1 (190-197) are diverse and cross-recognize similar peptides from both host self-proteins and bacterial proteins. EBV BZLF1 (190-197) can be used to study autoimmune diseases[1]. | [References]
[1] Misko I S, et al. Crossreactive recognition of viral, self, and bacterial peptide ligands by human class I-restricted cytotoxic T lymphocyte clonotypes: implications for molecular mimicry in autoimmune disease[J]. Proceedings of the National Academy of Sciences, 1999, 96(5): 2279-2284. DOI:10.1073/pnas.96.5.2279 |
|
|